The assay provides results in less than 3 hours.
Meaningful data integration and patient empowerment are driving next-generation diabetes technology.
Many remote patient monitoring and management solutions today require patients to communicate results to their health care professionals in manual, time-consuming and non-digitized channels. Qualcomm Life and Roche hope to create an improved process for sharing health information between health care providers and their patients.
The deal will help Roche develop combination therapies and identify cancer patients more accurately.